3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
3
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Burkitt Lymphoma
2
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoproliferative Disorders
1
Lymphoma, Primary Effusion
1
Lymphatic Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hematologic Neoplasms
1
Hematologic Diseases
1
GATA2 Deficiency
1
Bone Marrow Diseases
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclophosphamide
3
Tacrolimus
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Busulfan
2
fludarabine
1
Transplantation
1
Radiotherapy
1
Methotrexate
1
Health Promotion
1
Etoposide
1
Educational Status
1
Cyclosporine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Bone Marrow Transplantation
×
90 days
×
Clear all
No trials found.